🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 64 of 200 · A–Z by INN

  1. eltrombopag

    REVOLADE Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved

    B02BX05

  2. eltrombopag choline

    ALVAIZ Teva Pharma GmbH

    ORAL FDA: approved

  3. eltrombopag olamine

    REVOLADE INITIAL APPROVAL Amneal Pharma Europe Ltd

    ORAL FDA: approved · PMDA: approved

  4. eluxadoline

    TRUBERZI

    ORAL FDA: approved · EMA: withdrawn

    A07

  5. elvitegravir

    GENVOYA

    ORAL FDA: approved · EMA: approved

    J05AR

  6. elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide

    ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    FDA: approved

  7. elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide fumarate

    GENVOYA

    PMDA: approved

  8. elvitegravir/cobicistat/ emtricitabine/tenofovir disoproxil fumarate

    STRIBILD

    PMDA: approved

  9. emapalumab

    GAMIFANT

    EMA: refused

    L04AA39

  10. emapalumab-lzsg

    GAMIFANT

    INJECTION FDA: approved

  11. emb-

    NMPA: clinical trials

  12. embolic

    NMPA: clinical trials

  13. emedastine

    EMADINE

    EMA: approved

    S01GX06

  14. emedastine difumarate

    EMADINE

    OPHTHALMIC FDA: approved

  15. emicizumab

    HEMLIBRA

    INJECTION FDA: approved · EMA: approved · PMDA: approved

    B02BX06

  16. empagliflozin

    JARDIANCE Boehringer Ingelheim Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    A10BD19

  17. empagliflozin + linagliptin

    GLYXAMBI Boehringer Ingelheim Pty Ltd

    TGA: approved

  18. empagliflozin + metformin

    JARDIAMET 5 MG/500 MG Boehringer Ingelheim Pty Ltd

    TGA: approved

  19. empagliflozin, metformin hydrochloride

    EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

    FDA: approved

  20. emtricitabine

    DESCOVY Amneal Pharma Europe Ltd

    ORAL FDA: approved · EMA: approved

    J05AR19

  21. emtricitabine + rilpivirine + tenofovir alafenamide

    ODEFSEY Gilead Sciences Pty Limited

    TGA: approved

  22. emtricitabine + tenofovir alafenamide

    DESCOVY Gilead Sciences Pty Limited

    TGA: approved

  23. emtricitabine, tenofovir alafenamide

    EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    ORAL FDA: approved

  24. emulsifying ointment (for use only as a base combined with active ingredients)

    NULL

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources